Professor | Haishaerjiang Wushouer | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Haishaerjiang Wushouer
Contact Information	kaiser@bjmu.edu.cn
Language ability	Chinese, English
Province	Beijing

Upload Avatar (500 x 500)

Name

Haishaerjiang Wushouer

Contact Information

kaiser@bjmu.edu.cn

Language ability

Chinese, English

Province

Beijing

University/Lab Affiliation and Title	Peking University
Faculty	Pharmaceutical Sciences
Academic Background & Achievements	2018 PhD in Science: Peking University 2011 Master's in Science: Peking University 2009 Bachelor's in Science: Peking University
Work Experience	2020.12-Present - Peking University School of Pharmaceutical Sciences - Department of Pharmacy Administration and Clinical Pharmacy 2018.09-2020.11 - Chinese Academy of Engineering Strategic Consulting Center - Postdoctoral Researcher 2012.08-2017.03 - First Affiliated Hospital of Xinjiang Medical University - Pharmacist
Awards	2018: Outstanding Graduate of Beijing 2018: Outstanding Graduate of Peking University 2017: Peking University Three Good Student

University/Lab Affiliation and Title

Peking University

Faculty

Pharmaceutical Sciences

Academic Background & Achievements

2018 PhD in Science: Peking University
2011 Master's in Science: Peking University
2009 Bachelor's in Science: Peking University

Work Experience

2020.12-Present - Peking University School of Pharmaceutical Sciences - Department of Pharmacy Administration and Clinical Pharmacy
2018.09-2020.11 - Chinese Academy of Engineering Strategic Consulting Center - Postdoctoral Researcher
2012.08-2017.03 - First Affiliated Hospital of Xinjiang Medical University - Pharmacist

Awards

2018: Outstanding Graduate of Beijing
2018: Outstanding Graduate of Peking University
2017: Peking University Three Good Student

Areas of Focus	Economic burden of bacterial resistance and rational use of antibiotics
Publications	Influence of government price regulation on the price, volume and spending of antibiotics in China: a controlled interrupted time series study, Wushouer H, Luo Z, Guan X, Shi L, 2020 Secular trend analysis of antibiotic utilisation in China’s hospitals 2011–2018, a retrospective analysis of procurement data, Wushouer H, Zhou Y, Zhang X, Fu M, Fan D, Shi L, Guan X, 2020 The impact of physicians' knowledge on outpatient antibiotic use: Evidence from China's county hospitals, Wushouer H, Wang Z, Tian Y, Zhou Y, Zhu D, Vuillermin D, Shi L, Guan X, 2020 Medical insurance and healthcare utilization among the middle-aged and elderly in China: evidence from the China health and retirement longitudinal study 2011, 2013 and 2015, Zhou Y, Wushouer H, Vuillermin D, Ni B, Guan X, Shi L, 2020 Health care utilization and costs of patients with prostate cancer in China: Based on national health insurance database, 2015-2017, Bai L, Wushouer H, Huang C, Luo Z, Guan X, Shi L, 2020 Potentially inappropriate medications among elderly patients in community healthcare institutions in Beijing, China, Fu M, Wushouer H, Nie X, Shi L, Guan X, Ross-Degnan D, 2020 Differences in reimbursement listing of anticancer therapies in China: an observational study, Guan X, Zhang Y, Wushouer H, Shi L, Ross-Degnan D, Wagner AK, 2020 Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study, Xiaodong Guan, Haishaerjiang Wushouer, Mingchun Yang, et al., 2019

Areas of Focus

Economic burden of bacterial resistance and rational use of antibiotics

Publications

Influence of government price regulation on the price, volume and spending of antibiotics in China: a controlled interrupted time series study, Wushouer H, Luo Z, Guan X, Shi L, 2020
Secular trend analysis of antibiotic utilisation in China’s hospitals 2011–2018, a retrospective analysis of procurement data, Wushouer H, Zhou Y, Zhang X, Fu M, Fan D, Shi L, Guan X, 2020
The impact of physicians' knowledge on outpatient antibiotic use: Evidence from China's county hospitals, Wushouer H, Wang Z, Tian Y, Zhou Y, Zhu D, Vuillermin D, Shi L, Guan X, 2020
Medical insurance and healthcare utilization among the middle-aged and elderly in China: evidence from the China health and retirement longitudinal study 2011, 2013 and 2015, Zhou Y, Wushouer H, Vuillermin D, Ni B, Guan X, Shi L, 2020
Health care utilization and costs of patients with prostate cancer in China: Based on national health insurance database, 2015-2017, Bai L, Wushouer H, Huang C, Luo Z, Guan X, Shi L, 2020
Potentially inappropriate medications among elderly patients in community healthcare institutions in Beijing, China, Fu M, Wushouer H, Nie X, Shi L, Guan X, Ross-Degnan D, 2020
Differences in reimbursement listing of anticancer therapies in China: an observational study, Guan X, Zhang Y, Wushouer H, Shi L, Ross-Degnan D, Wagner AK, 2020
Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study, Xiaodong Guan, Haishaerjiang Wushouer, Mingchun Yang, et al., 2019

Bacterial Resistance Economic Burden Antibiotics Rational Use Health Policy Pharmaceutical Management Clinical Pharmacy Public Health Healthcare Costs China

Xiaodong Guan - Peking University

Jing Chen - Peking University

Xiaoyan Nie - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us